The US Oncology Network in the News
In the News
Read about us in the news to learn how the more than 1,200 physicians in The US Oncology Network advance cancer care in America.
Broadcast/Video
OncLive: Dr. Monk on the Utility of Tisotumab Vedotin in Recurrent Cervical Cancer
Investigating Combinations in Recurrent or Metastatic Cervical Cancer
A Breast Cancer Roundtable: CDK4/6 Inhibition, HER2-Positive Disease, and the Role of Immunotherapy
Advanced Breast Cancer: Expert Perspectives On Recent Progress
Dr. Burke on Current FDA Indications for BTK Inhibitors in B-Cell Malignancies
Provider Responsibility to Cost Burden for mBC Therapy
Patient Journey and Development of Metastatic Breast Cancer
OncologyTube: RWE on the Impact in the Oncology Community
OncLive: Classification of Triple Negative Breast Cancer
Oncology Times: Oncology Care Model Supports Practice & Benefits Medicare’s Bottom Line
Oncology Times: Measuring Quality of Cancer Care in Changing Health Care Landscape
KGW-TV 8: Portland woman finds success in clinical trial for breast cancer
OncLive: ESMO 2019: Dr. O’Shaughnessy Highlights Progress in Breast Cancer
Oncology Business Review: Joyce O’Shaughnessy, MD, on differentiating CDK4/6 inhibitors
Oncology Business Review: Ira Zackon, MD, elaborates on medically integrated pharmacies
Medscape: Guiding Patients To and Through Second Opinions
OncLive: Dr. Sharman on the Potential Future of Acalabrutinib in CLL
Healio: Oncology care model enhances quality, increases value
OncologyTube: MONALEESA-7 Trial in Premenopausal Metastatic Breast Cancer
OncologyTube: ImPassion130 Trial Outcomes
OncologyTube: EMBRACA Trial in HER2 Metastatic Breast Cancer
OncologyTube: Data on SOPHIA Trial in HER+ Metastatic Breast Cancer
The Video Journal of Oncology: Multiple treatment options for prostate cancer
The Video Journal of Oncology: ASCO 2019 | What to expect in prostate cancer therapy in the future
Cancer Therapy Advisor: Advanced Soft Tissue Sarcomas: Dox + Olaratumab vs. Dox + PBO
Healio: CDK 4/6 Inhibitors Help Make Advanced Breast Cancer ‘Chronic Disease’ For Many Patients
Medscape: From Oncology Care to Primary Care: Reassuring Survivors
OncLive: OncLive News Network On Location: In Chicago Saturday, June 1
Oncology Business Review: Neelima Denduluri, MD, discusses outcomes from the ImPassion130 trial
OncLive: Dr. Nadler on the Impact of Immunotherapy in Squamous NSCLC
UroToday: The Changing Therapeutic Landscape of Prostate Cancer-Nicholas Vogelzang
Oncology Business Review: Ben Jones offers his opinion on priority policy concerns
OncLive: Dr. O’Shaughnessy on Clinical Implications of the TEXT and SOFT Trials in Breast Cancer
Patient Power: Is Chemo Safe for CLL Patients With a 17p Deletion?
OncLive: Dr. Fleming Discusses Importance of QoL in Prostate Cancer
Oncology Business Review: Mark T. Fleming, MD, regarding the Aramis study in prostate cancer
Oncology Business Review: Nicholas Vogelzang, MD, FASCO, FACP, regarding sipuleucel-T in mCRPC
WCPO-TV: New therapy helping people with lymphoma
American Journal of Managed Care: Dr. Jeff Sharman on Using Precision Medicine to Treat CLL
Targeted Oncology: Data Suggest Potential for Immunotherapy in HCC
Oncology Tube: Can a Rituximab Biosimilar Replace Rituximab
Oncology Tube: Lyra Trial in Newly Diagnosed MM
Oncology Tube: Research Examining Gilteritinib in Newly Diagnosed AML
Oncology Tube: Phase 3 Study Investigating Ibrutinib in Older CLL Patients
Oncology Tube: Outcomes of CAPTIVATE Study
Oncology Tube: Phase 3 Study Investigating Ibrutinib in Younger CLL Patients
Oncology Tube: Rituximab Biosimilars in Follicular Lymphoma
Oncology Tube: The CLL-14 Studies Importane in Determining CLL Treatment Strategies
American Journal of Managed Care: Dr. Robert Rifkin on Lack of Education Surrounding Biosimilars
OncLiveTV: Dr. Rifkin on Split Dosing of Daratumumab in Myeloma
HemOnc Today: Recent trials impact first-line management of chronic lymphocytic leukemia
Oncology Business Review: John Burke, MD, elaborates on the BEAT AML umbrella study
Oncology Business Review: John Burke, MD, speaks to the reliability of the FLT3 mutation test
Oncology Business Review: John Burke, MD, regarding gilteritinib in acute myeloid leukemia treatment
Oncology Business Review: Robert Rifkin, MD, discusses the outcomes of the TOURMALINE-MM3 study
Oncology Business Review: Habte Yimer, MD, speculates on the future of anti-BCMA CAR-T cell therapy
Cancer Therapy Advisor: Results from LYRA Phase 2 Study of Frontline Multiple Myeloma Therapy
Cancer Therapy Advisor: A Potential Rituximab Biosimilar?
Cancer Therapy Advisor: ASH 2018: New Developments in Treatment of Multiple Myeloma
Cancer Therapy Advisor: ASH 2018: Practice-Changing Findings on Treatment of Lymphoma
Denver ABC 7: Breast cancer survivor’s recovery eased with cold cap that helps prevent hair loss
OncLive TV: Dr. Paulson Discusses the Current Treatment for NETs
Oncology Business Review: Dr. Vogelzang Discusses PROSPECT Trial for Prostate Cancer
Oncology Business Review: Debra Patt, MD on NGS and Cancer: Combatting the Hazards of Misinformation
Oncology Business Review: Debra Patt, MD on Will NGS-Based Cancer Tests Become Routine?
Oncology Buisness Review: Debra Patt, MD on Next-Gen Sequencing is Transforming Oncology Practices
Oncology Business Review: Neelima Denduluri, MD, comments on the role of CDK4/6 inhibitors
Oncology Business Review: Neelima Denduluri, MD, tells us about the recent updates to breast cancer guidelines
Oncology Business Review: Nwelima Denduluri, MD, offers opinion on the PERSEPHONE trial in early HER2+ breast cancer
Oncology Business Review: Neelima Denduluri, MD, on the outcomes of the SANDPIPER study presented at ASCO 2018”
Ecancer TV: ASCO 2018 Conference Round-Up
Ecancer TV: Atezolizumab with Chemotherapy Improves PFS in Squamous NSCLC
OncLiveTV: Therapy Selection in BRCA-Mutated Ovarian Cancer (Panel video with Bradley J. Monk, Arizona Technology, The Network)
OncLive TV: Adjuvant Sunitinib’s Role in the Treatment of RCC
OncLiveTV: Dr. Paulson on the Importance of Symptom Control
Oncology Tube: Carflizomib Doing Patterns – Data presented for appropriate dosing of Carfilzomib
Oncology Business Review: Michael Boxer, MD, considers broader uses for fostamatinib
KTNV-TV: Advances in brain cancer treatment gives patients new hope
Oncology Business Review: Lalan Wilfong, MD, provides opinion on how OCM is changing his practice
Oncology Business Review: Lalan Wilfong, MD, shares lessons from his experience participating in OCM
Oncology Business Review: Debra Patt, MD, on what tele-health brings to cancer care
Patient Power: ASH 2016 Expert Roundtable: What does emerging CLL research mean for patients?
Oncology Tube: ASH 2016 Lymphoma News
OncLiveTV: Dr. Kolibaba on Efficacy of Entospletinib in Mantle Cell Lymphoma
OncLiveTV: Dr. Kolibaba on Entospletinib Activity in Mantle Cell Lymphoma
OncLiveTV: Dr. Kolibaba on Mechanism of Action with Entospletinib in MCL
OncLiveTV: Dr. Burke on a Study Investigating Obinutuzumab in Large B-Cell Lymphoma
healtheo360: Vital Conversations: David J. Andorsky from Rocky Mountain Cancer Centers (Part 1 of 2)
healtheo360: Vital Conversations: David J. Andorsky from Rocky Mountain Cancer Centers (Part 2 of 2)
healtheo360: Vital Conversations: Dr. Kathryn Kolibaba from Compass Oncology
healtheo360: Vital Conversations: Dr. John Burke from Rocky Mountain Cancer Centers
HemOnc Today: Symposium highlights diversity of breast cancer biology, targets
HemOnc Today: Genomic profiling may identify subset of women who benefit from extended letrozole
HemOnc Today: Combination active in subset of women with triple-negative breast cancer
HemOnc Today: Anti-CD19 CAR T cells may offer new option for difficult-to-treat patients with DLBCL
Patient Power: ASH 2016: Hodgkin Lymphoma News
Patient Power: ASH 2016: Lymphoma Research News Update
OncLiveTV: Dr. Blum on Takeaways from ABC Trials for Breast Cancer
OncLiveTV: Dr. Nicholas Robert on MA.17R Trial for Patients With Early-Stage Breast Cancer
Oncology Business Review: Debra Patt, MD, tells us how chemotherapy costs figure into total care
Patient Power: ASCO 2016 CLL Research Update
Patient Power: 2016 Lymphoma Research Update
Patient Power: ASH 2015: What Could a Second-Generation BTK Inhbitor Mean for Patients?
Patient Power: ASH 2015 Coverage: Emerging Approaches for Treatment-Resistant CML Patients
Patient Power: ASH 2015 News: Emerging Approaches for Elderly Hodgkin Lymphoma Patients
Patient Power: Dr. Jeff Sharman: My Perspective on ASH 2015 News
Patient Power: Follicular Lymphoma News From ASH 2015
OncLiveTV: Dr. Sharman on Entospletinib in Patients with CLL
OncLiveTV: Dr. Joanne Blum on the EMBRACA Trial in Metastatic BRCA-Mutant Breast Cancer
OncologyTube: Ibrutinib or Idelalisib Selecting Appropriate Therapy for Relapsed CLL
OncologyTube: Entospletinib Why It’s Different Than Fostamatinib
CLL Transformed in Last 5 Years, Hope is to Leave Chemotherapy Behind
OncologyTube: Bcl-2, BTK, and PI3 Inhibitors Among Highlights Presented at ASH 2015
Patient Power: Advances in Treating High-Risk CLL
Patient Power: What Could Emerging Immunotherapy Research Mean for Lung Cancer Patients
Patient Power: Advances in Immuno-Oncology Research
OncLiveTV: Dr. Spira on the POPLAR Study NSCLC
Fox News: Hospitals being overpaid for medical treatment?
CBS Evening News: Consumer protection on Obamacare delayed
OncLiveTV: Dr. Vogelzang Discusses the Addition of Chemotherapy to ADT in Men With Prostate Cancer
OncLiveTV: Role of Lapatinib in HER2-Positive Breast Cancer
OncLiveTV: Dr. Vogelzang on Two Analyses of the ALSYMPCA Trial
OncUView TV: ASCO 2013 – Nicholas Vogelzang, MD, discusses Xofigo (radium Ra 223 dichloride)
OncLiveTV: Dr. O’Shaughnessy on Everolimus in Breast Cancer
OncLive TV: Managing Bone Health in Metastatic Breast Cancer
OncLiveTV: Ben Jones on the Impact of Sequestration on Reimbursement
KTNV-TV ABC 13 : Partial Breast Radiation Therapy
The Today Show: Family faces breast cancer together
ABC 15: Screening still vital in prostate cancer, Arizona doctor discusses treatments
PBS News Hour: Drug Hoarders, Manufacturing Cuts Exacerbate Shortage of Key Medications
Inside Business Reports: Advancements in Cancer Treatment and Care
21st Century Health: Innovative Cancer Treatment Solutions
WFMJ-TV NBC: Providing cancer treatment to those who cannot afford it
Bloomberg: McKesson to purchase US Oncology
Radio
Bark & Wag: Dr. Curtis Mack shares his story on how his dogs helped him fight cancer
Health Professional Radio: The San Antonio Breast Cancer Symposium 2017
Health Professional Radio: NERLYNX – Breast Cancer Treatment
Health Professional Radio: NERLYNX Update
The Tom Joyner Morning Show: Get Well Wednesday: Dr. Tia Olds Answers your Cancer Questions
Articles
Precision Medicine Will Drive New Standards of Care in the Post-COVID-19 World
New U.S. health crisis looms as patients without COVID-19 delay care
Early Data Suggest Acalabrutinib May Benefit Patients With Advanced COVID-19
Blood Test Detects Over 50 Different Cancers With a 0.7% False-Positive Rate
Proton Therapy Improves Outcomes, Reduces Radiation Side Effects in Patients with Cancer
Don’t Delay Cancer Care During COVID-19 Crisis
Platinum-Sensitive, Recurrent Ovarian Cancer: Trial of Surgery + Chemo With and Without Bevacizumab
OncLive: Homing in on Targeted Treatment Strategies in Breast Cancer
OncLive: Breast Oncologists Aim to Address Key Unanswered Questions With Novel Research Efforts
OncLive: Advanced Practitioners Improve Quality Care Value
Targeted Oncology: O’Shaughnessy Discusses Emerging Data That Could Affect TNBC Treatment Options
OncLive: The FDA Could Help Address Financial Toxicity During the Approval Process
OncLive: Can New Oncology Payment Programs Help Stabilize Medicare?
Women: Three Things you can do to Prevent Breast Cancer
Women’s Health: 10 Subtle Signs Of Breast Cancer That Have Nothing To Do With Lumps
Fox 7 News Austin: Breast Cancer Awareness Month: New BRCA gene mutation guidelines
Modern Healthcare: Minnesota Blues strikes up outcomes-based cancer care arrangement
Managed Healthcare Executive: Innovative Risk-Based Arrangement Could Change Cancer Care
The Columbian: For two moms with breast cancer, it was all about weathering the storm
Las Vegas Review Journal: Las Vegas Mayor Carolyn Goodman shares story of cancer fight
American Journal of Managed Care: Lessons From the Field: How Practices Are Succeeding Under OCM
OncLive: CMS Should Broaden Coverage for Germline Mutation Testing
HealthTech: How Are Predictive Analytics Applications Changing Oncology?
OncLive: Vogelzang Highlights Decades of Innovation in Prostate Cancer
American Journal of Managed Care: Who’s Next in Line for New Payment Models? Everybody!
Oncology Practice Management: Decision Time Is Approaching for Practices in the Oncology Care Model
OncLive: Proton Therapy: A Path to Improved Outcomes and Quality of Life
OncLive: Efficacy Data Support Acalabrutinib Across CLL Settings
HelloGiggles: Your questions about ovarian cancer answered: from early symptoms to treatment
OncLive: Personalized Medicine Progressing in Premenopausal Breast Cancer
The ASCO Post: Lenvatinib Plus Pembrolizumab Shows Activity in Advanced Urothelial Cancer
OncLive: Practical Treatment Questions Surface in HR-Positive Metastatic Breast Cancer
OncLive: What’s Keeping CAR T-Cell Therapies From the Outpatient Setting?
CURE: Split Dosing Has Comparable Results in Myeloma Treatment
Targeted Oncology: Expert Shares Data for Split Dosing Schedule of Daratumumab in Multiple Myeloma
OncLive: Real-World Ibrutinib Survival Data in MCL Consistent With Clinical Trials
OncLive: Real-World Evidence Supports Split Daratumumab Dosing in Myeloma
Oncology Practice Management: MIPS: How to be successful today and in the future
OncLive: Developing Alternative Payment Models that Providers and Commercial Payers Support
OncLive: Luminary Awards in GI Cancers Honor Distinguished Leaders
The Columbian: Vancouver doctor in select company having completed 1,000th robot surgery
Nature: Precision therapies take aim at non-Hodgkins lymphoma
Las Vegas Review-Journal: Healthy lifestyle, diet reduce risk of cancer
Las Vegas Review-Journal: New treatments bring hope to patients
Zwivel: What Is Male Breast Cancer? Symptoms, Causes, and Treatment
Becker’s Hospital Review: Understanding the Future Cancer Patient
OncLive: A Perfect Storm Brews for Biosimilar Marketing
Women: Three things you can do to prevent breast cancer
Targeted Oncology: Novel Agents are Changing the Face of Metastatic TNBC
Oncology Practice Management: Dispelling Misconceptions about HCC Coding
PM360: Solving the Adherence Problem
Rare Disease Report: Exploring Treatment Challenges for Merkel Cell Carcinoma & Other Rare Cancers
CURE: Erdafitinib Shows Promise in Advanced FGFR-Positive Bladder Cancer
OncLive – Dr. Jotte on the IMpower131 Findings in Squamous NSCLC
STAT News: Grail’s Cancer Blood Test Shows ‘Proof of Principle,’ but Challenges Remain
OncLive: Atezolizumab Plus Chemo Extends PFS in Frontline Squamous NSCLC
BioPharma Dive: ASCO18 – Tecentriq Scores Again in Lung cancer, but Keytruda Looms in Background
CURE: Ounce of Lung Cancer Prevention, Worth a Pound of Cure
GenomeWeb: Advanced NSCLC Trials Demonstrate Potential of First-Line Immunotherapy
Cancer Network: PFS Boost with Atezolizumab in Advanced Squamous NSCLC
HemOnc Today: First-Line Atezolizumab Improves PFS for Advanced Squamous Non-Small Cell Lung Cancer
Medscape: Top 5 Lung Cancer Presentations at ASCO 2018
Oncology Business Review:: ASCO Highlights for Saturday, June 2, 2018
OncLive: 5 Key Elements Needed to Achieve Success With the Oncology Care Model
PM360: Four Key Questions about Payer/Provider Strategies
Journal of Clinical Pathways: From Clinical Use to Reimbursement: An Update on Biosimilars in the US
OncLive: A Collaborative Model for Advanced Practice Providers Empowers Success
Journal of Clinical Pathways: Ehancing Care Coordination Supports Transition Toward Value-Based Care
Targeted Oncology: Panelists Highlight Ways to Ease Transition to Value-Based Care
Managed Healthcare Executive: Seven diseases benefiting from genetic tests
OncLive: Classification of Triple Negative Breast Cancer
The Hill: Unequal Medicare Payments Fuel Health Care Consolidation Trends
OncLive: Patient Collaboration Can Help Solve “Crisis” in Cancer Care
Cure: FDA: Approves Frontline Verzenio for Advanced HR-Positive, HER2-Negative Breast Cancer
OncLive: FDA Approves Frontline Abemaciclib for HR+/HER2- Advanced Breast Cancer
CURE Today: The History Behind the Development of CAR-T Cell Therapy
Radiology Today: Managing to Succeed: Advancing Value-Based Cancer Care
OncLive: Keeping a Tight Rein on Unnecessary Expenditures in Oncology Practice
CURE Today: MSI-H Status: What you need to know
ASH Clinical News: What are Biosimilars?
Oncology Times: Development of Neratinib for Early-Stage HER2+ Breast Cancer Patients
OncLive: Von Hoff’s Quest for a Cure in Pancreatic Cancer
The ASCO Post: Where Are We Now in Triple-Negative Breast Cancer?
Managed Healthcare Executive: Four oncology treatment advances to watch
OncLive: Angiogenesis Inhibitor Tested in Mesothelioma Trial
Oncology Times: Managing the Complexities of Cancer Care With Information Technology
Oncology Business Management: MedPAC’s Latest Part B Proposals Would Raise the Cost of Care
Morning Consult: Modernize Medicare With Site Neutral Payment
Morning Consult: Medicare Proposal to Better Align Payments Deserves Broad Support
Las Vegas Review-Journal: New treatments give hope to patients with tumors like McCain’s
Targeted Oncology: O’Shaughnessy Shares Novel Therapeutic Strategies for Treating Metastatic TNBC
OncologyLive: From Bench to Bedside: O’Shaughnessy Keeps Patients in Focus
OncologyLive: Novel Therapeutic Strategies for Metastatic TNBC
HemOnc Today: Supreme Court ruling on biosimilars ‘a win’ for patients
HemOnc Today: Unknowns of interchangeability likely not problematic with monitoring, FDA guidance
Pharmaceutical Commerce: New science energizes the cancer market
CenterWatch: US Oncology Research, Epizyme collaborate
Las Vegas Business Press: Comprehensive Cancer Centers holds rare clinical trials
Vancouver Business Journal: Compass Oncology: Serving community with cutting-edge treatment
Oncology Practice Management: Best Practices in Oncology an Evolving Process
HIStalk: Carrot or Stick? Physician Compensation in Value-Based Cancer Care Delivery
WVEC-TV: Clinical trials expand treatment options for cancer patients in Hampton Roads
ACCC Buzz: What Happened in Vegas: Highlights from the 2017 Cancer Center Business Summit
Las Vegas Review-Journal: Beloved doctor Nicholas Vogelzang won’t stop fighting cancer
Oncology Business Management: Joining Forces Without Loss of Independence
Managed Healthcare Executive: Watch list 2017: Top therapeutic areas
Specialty Pharmacy News: CMS Launches ‘Transformative,’ ‘Monumental’ Oncology Care Model
Denver Business Journal: Denver doctor on leading edge of treating neuroendocrine cancer
U.S. News & World Report: What to Look for in a Hospital if You Need Lung Cancer Surgery
U.S. News & World Report: Stomach Cancer: Awareness and Advances Needed
HIStalk: Physician Engagement in Cancer Care Delivery Redesign
OncologyLive: Oncology Practice Vitality Depends on Leadership
Lung Disease News: Center Enrolls First Lung Cancer Patient in Advanced Phase 3 Clinical Trial
Specialty Pharmacy News: With CMS’s OCM Set to Start July 1, The US Oncology Network Preps Practices
HealthLeaders: Oncology Care Model Kicks Off
Targeted Oncology: Anthracycline Regimen Superior in HER2-Negative Breast Cancer
The Hill: Congress: Don’t dial back site-neutral payment reforms
STAT News: Breast cancer study shows benefit to extended treatment with aromatase inhibitors
Oncology Business Management: Some Prefer Pay Cuts to Inflexible CMS Metrics
Pharmaceutical Commerce: Oncology: a new era in therapies; same cost concerns
Managed Healthcare Executive: New oncology payment model accelerates shift to value
Prevention.com: 7 Worst Things People Lie To Their Doctors About
Reader’s Digest Online: 17 Common Lies You Tell Your Doctor (And Why You Need to Just Stop)
HIStalk: Empowering Value-Based Technologies with Standardization, Agreement, and Leadership
Oncology Business Management: Top 3 Must Do’s to Prepare for Managed Care in 2016
HealthLeaders: Oncology Bundling Model Aims to Incentivize Doctors
SheKnows.com: Signs your migraine is more than just a minor headache
SheKnows.com: Nine health myths about your boobs you can finally put to rest
Ocala Star Banner: Promising new cancer drug helping Ocala woman
OncologyLive: Oncologists Must Take Lead Role in Developing Clinical Pathways
Oncology Times: ASCO Issues Recommendations to Improve Oncology Clinical Pathways
OncologyLive: Tackling Challenging Patient Populations in DLBCL
OncologyLive: Frontline Brentuximab Vedotin Generates 76% Complete Remission Rate in DLBCL
Oncology Business Management: Compatibility Check: Can Precision Medicine and Pathways Co-Exist?
Fox News: Moms with BRCA breast cancer gene mutations face tough decisions
Oncology Times: Critiquing ASCO’s Cancer Care Value Plan
HealthDay News: Could Common Diapetes Drugs Help Fight Leukemia?
LiveScience.com: Skeletal System: Facts, Function & Diseases
HealthDay: 1 in 3 Women Survive Ovarian Cancer a Decade or More: Study
OncologyLive: O’Shaughnessy Details Strategies to Strengthen ER Blockade in MBC
Oncology Business Management: CMS Standards for Reporting Call for Advanced Technology, Training
OncologyLive: Shifting Reform Landscape Is Perilous for Small Practices
HealthDay News: Cell Damage Occurs When People Have CT Scans: Study
LiveScience.com: Lymphatic System: Facts, Functions & Diseases
Yahoo!: One Woman’s Story Highlights the Hidden Skin Cancer Risks for People of Color
U.S. News & World Report: Preparing for a Baby After Cancer
Everyday Health: First Breast, Now Lung: One Woman’s Fight Against Cancer
Oncology Business Management: More Effort Needed to Understand Value Breadth of Molecular Testing
Managed Care: Biosimilars Change the Market But Still Face Many Hurdles
BlackDoctor.org: Condition Critical: Fighting Breast & Cervical Cancers In Black Women
Roll Call: A Common-Sense Medicare Solution: Site-Neutral Payment Reform | Commentary
Examiner.com: Joel M. Schwartz, DO increases your knowledge regarding skin cancer awareness
Oncology Times: CLL: New Drugs Bring Paradigm Shift for High-Risk Disease
Specialty Pharmacy Continuum: Cancer Drugs Help SPs Show Their Value
Oncology Business Review: Novel Therapies for Leukemia Attract Attention at ASCO 2014
Bloomberg: Bristol-Myers, Merck Immune Therapy Promising in Cancer Trials
HealthDay News: Popular Crohn’s, Colitis Drugs Not Linked to Short-Term Cancer Risk: Study
The New York Times: Study May Alter Approach to Prostate Cancer
OncologyLive: Vogelzang Sees Early Chemo Strategy as Landmark Change in Prostate Cancer Therapy
Portland Business Journal: Oregon docs find good news with cancer risk assessment
Las Vegas Review-Journal: Cancer anxiety a factor in treatment
Roll Call: It’s Time to Level the Playing Field in Cancer Care
Pharmaceutical Commerce: Bending the cost curve in oncology
HealthDay News: New Colon Polyp Removal Method May Be Easier on Patients
HealthDay News: HPV-Linked Oral Cancers May Not Be ‘Contagious’
Forbes: Death Rates From Pancreatic Cancer Continue To Climb: Most Other Cancers Declining In Europe
Forbes: Is There A Link Between Prostate Cancer And Chronic Inflammation?
HealthDay News: Experimental Breast Cancer Drug Seems Safe, Effective for Advanced Disease
The Cancer Letter: What the Physician Pay Report Won’t Tell You
Modern Healthcare: Denying access to big cancer centers may undermine narrow networks
Forbes: New Urine Test Accurately Predicts Recurrence Of Bladder Cancer
Forbes: Guideline Updated Regarding Role of Sentinel Lymph Node Biopsy In Early Stage Breast Cancer
HealthDay News: Targeted Radiation Might Help Fight Advanced Breast Cancer: Study
HealthDay News: New Guidelines Might Limit Need for Lymph Node Removal for Breast Cancer
HealthDay News: Colon Cancer Cases Decline for Older Americans
Forbes: How Should We Manage Early Prostate Cancer?
OncologyLive: Study Supports First-Line Eribulin Therapy in Metastatic Breast Cancer
HealthDay News: Ovarian Cancer Gene May Point to Early Removal of Ovaries: Study
OncologyLive: PARP Inhibitor BMN 673 Advances in Breast Cancer Study
HealthDay News: Ovarian Cancer Gene May Point to Early Removal of Ovaries: Study
OncologyLive: PARP Inhibitor BMN 673 Advances in Breast Cancer Study
The Hill: Equalize payments for cancer care
Forbes: Cervical Cancer: Detectable and Preventable
Community Oncology: Policy prescriptions to fix our ailing delivery system
HealthDay News: Experimental Vaccines May Extend Life in Pancreatic Cancer
HealthDay News: Blood Test Might Help Spot Pancreatic Cancer Early
Las Vegas Review-Journal: Brave risk helps women cheat death
Modern Healthcare: Seiden named CMO of McKesson division, oncology group
Managed Care: Health Plans Lag Providers On Molecular Profiling
Vegas Inc: Patient profile: A conversation with Paul Bodner
MedPageToday: Oncology Clinics Caught in Financial Vise
The Health Journal : Genetic Testing: Knowing The Family Tree and Family Genes
Specialty Pharmacy News: Molecular Diagnostics Initiative Should Improve Care, Reduce Costs
MedPage Today: No Excess Risk of AML, MDS after Chemo
Medscape: The Right EHR for an Oncology Practice
Biotechnology Healthcare: Will Clinical Pathways Work?
The New York Times: Insurers Test New Cancer Pay Systems
The Wall Street Journal: In Treating Cancer, Insurer Tries New Way to Pay Docs
Chicago Tribune: Patient Assistance Support
Bureau of National Affairs: BNA Q & A: Risk Contracting Model for Oncologists and Payers
HemOnc Today: Small cell lung cancer requires complex therapeutic strategies
Tyler Morning Telegram: Clinical Trials Pivotal In Drug Development
Information Week: BI Made Easier For Healthcare
Odessa American Daily: Clinical Trials
HemOnc Today: REMS for ESAs: The FDA mandated program is under scrutiny
HemOnc Today: Hematologic Malignancies
North Bay Business Journal: Redwood Regional joins nationwide network of oncologists
Houston Business Journal: Collaboration Creates Cancer Center
Woodlands Online: Memorial Hermann, Texas Oncology And US Oncology Partner
Las Vegas Review Journal: TREATMENT QUALITY: Care, research attract visitors
Dallas Morning News: Cancer doctors weigh in with opinions on travel
Dallas Morning News: The trip treatment: Traveling during cancer care
Oncology Times: Cancer Care Pathways Catching on with Payers
Pharmawire article on Celgene’s Revlimid
Pharmawire article on melanoma May 2010
Houston Business Journal: US Oncology unveils new brand campaign
Wall Street Journal article Women’s Health
Nevada Business Magazine: Nevada Business Magazine – Healthcare Heroes
James Kilber profile for Top Administrator in Southern Nevada (page 7)
Nevada Business Magazine: Nevada Business Magazine – Healthcare Heroes
Dr. Mary Ann Allison profile for Caregiver of the Year in Southern Nevada (page 8)
Tampa Bay Times: Florida Cancer Affiliates opens site in New Port Richey
US News & World Reports: Experimental Drugs Do Battle Against Advanced Prostate Cancer
Reuters: Breast cancer kills older women more often
Studies
Managed Care: Molecular Monitoring of Response In Patients With Chronic Myeloid Leukemia
Podcasts
Journal of Clinical Pathways: OCM Pilot Program Successes at The US Oncology Network
Blogs
Responding to Coronavirus, Cancer Researchers Reimagine Clinical Trials
mcolBLOG: Getting More Precise About Precision Medicine
Software Advice: US Oncology iKnowMed EHR Medical Software
ASCO 2010-Cabazitaxel second line for prostate castration resistant cancer